To assess the long-term efficacy of electroacupuncture (EA) on cognitive symptoms in Alzheimer's disease (AD) and examine the time-dependent relationship of treatment effects, highlighting its clinical significance.
Key Findings:
Significant improvements in ADAS-Cog scores after 24 weeks of EA treatment (p < 0.05).
Sustained benefits were observed during the 4-week follow-up period.
Improvements noted in activities of daily living and behavioral and psychological symptoms.
Interpretation:
EA shows promise as a nonpharmacological intervention for improving cognitive symptoms in AD, with potential for sustained benefits, suggesting implications for clinical practice.
Limitations:
The study was limited to a single center, which may affect generalizability and introduce potential biases.
The sample size was relatively small, potentially limiting the robustness of findings.
Conclusion:
EA may be an effective treatment for cognitive symptoms in AD, warranting further research to confirm these findings, explore mechanisms, and identify optimal treatment protocols.
Three recently published studies from Cedars-Sinai investigators have deepened knowledge of how changes in the eye are linked to indicators of Alzheimer’s disease in the brain.
